High expression of Lewisy/bantigens is associated with decreased survival in lymph node negative breast carcinomas
Open Access
- 28 July 2005
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 7 (5) , R780-7
- https://doi.org/10.1186/bcr1305
Abstract
Introduction: There is sufficient evidence that blood group related Lewis antigens are tumour-associated molecules. The Lewisy and Lewisb antigens are complex carbohydrates that are over-expressed by breast, lung, colon and ovarian cancers. The SC101 mAb is a unique Lewisy/b binding antibody that binds to native and extended Lewisy and Lewisb haptens, displaying no cross reactivity with H type 1, H type 2, Lewisx or normal blood group antigens. Methods: Immunohistochemical detection of Lewisy/b was performed on 660 formalin-fixed, paraffin embedded breast tumour specimens using a streptavidin-biotin peroxidase technique. Tissue from these patients had previously been included in tissue microarrays. This cohort comprises a well characterized series of patients with primary operable breast cancer diagnosed between 1987 and 1992, obtained from the Nottingham Tenovus Primary Breast Carcinoma Series. This includes patients 70 years of age or less, with a mean follow up of 7 years. Results: Of the breast carcinomas, 370 of 660 (56%) were negative for Lewisy/b expression, 110 (17%) cases showed a low level of expression (75% of positive cells). We found significant positive associations between histological grade (p < 0.001), Nottingham Prognostic Index (p = 0.016), tumour type (p = 0.007) and the level of Lewis y/b expression. There was a significant correlation between the proportion of Lewisy/b positive tumour cells and survival in lymph-node negative patients (p = 0.006). Conclusion: The unique epitope recognised by SC101 mAb on Lewisy/b hapten is over-expressed on breast tumour tissue compared with normal breast. In this large series of invasive breast cancers, higher expression of Lewisy/b was more often found in high grade and poor prognosis tumours compared to good prognosis cancers. Moreover, in lymph node negative breast carcinomas, over-expression of Lewisy/b hapten was associated with significantly decreased patient survival.Keywords
This publication has 26 references indexed in Scilit:
- Breast Cancer Progression and Expression of Blood Group-Related Tumor-Associated AntigensHybridoma, 2000
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinomaHistopathology, 1995
- Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐upHistopathology, 1994
- Development of Second Generation Monoclonal Antibodies Recognising Lewisyy/bAntigen by Anti-Idiotypic ImmunisationHybridoma, 1993
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long‐term follow‐upHistopathology, 1992
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Immunohistochemical studies of blood group-related antigens in human superficial esophageal carcinomasCancer, 1991
- Altered expression of Lewis blood group and related antigens in fetal, normal adult and malignant tissues of the uterine endometriumVirchows Archiv, 1990